Literature DB >> 11385246

Epidemiological trends in pancreatic neoplasias.

B Simon1, H Printz.   

Abstract

Primary prevention is the most effective approach to reduce the incidence of pancreatic cancer. Epidemiological studies have contributed to the identification of risk factors for pancreatic cancer, suggesting an association with age, various medical conditions, environmental and lifestyle risk factors, and occupational and genetic conditions. Age is the strongest risk factor. The most consistently identified environmental risk factor is smoking, but there is less certainty concerning dietary factors. Studies have suggested a positive association with high energy intake, cholesterol and meat, while vegetable and fruit intakes are probably protective. Patients with chronic pancreatitis and new onset of diabetes mellitus have a low but increasing risk of having or developing pancreatic cancer. There is strong evidence for the association of hereditary pancreatitis or cystic diseases of the pancreas and pancreatic cancer. A family history of pancreatic cancer is an important risk factor, but only a small proportion can be linked with known familial cancer syndromes. Thus, additional yet unidentified predisposing risk factors have to be assumed. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2001        PMID: 11385246     DOI: 10.1159/000050648

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  8 in total

1.  Variants of bcl-2 specific siRNA for silencing antiapoptotic bcl-2 in pancreatic cancer.

Authors:  M Ocker; D Neureiter; M Lueders; S Zopf; M Ganslmayer; E G Hahn; C Herold; D Schuppan
Journal:  Gut       Date:  2005-09       Impact factor: 23.059

2.  Impact of calcifications on diagnostic yield of endoscopic ultrasound-guided fine-needle aspiration for pancreatic ductal adenocarcinoma.

Authors:  Anoop K Koshy; Rao B Harshavardhan; Ismail Siyad; Rama P Venu
Journal:  Indian J Gastroenterol       Date:  2019-03-22

3.  Mortality predictions for esophageal, stomach, and pancreatic cancer, Ireland, up to 2015.

Authors:  P O'Lorcain; S Deady; H Comber
Journal:  Int J Gastrointest Cancer       Date:  2006

4.  18F-fluorodeoxyglucose positron emission tomography in the diagnosis of small pancreatic cancer.

Authors:  Keiichi Okano; Keitaro Kakinoki; Shintaro Akamoto; Masanobu Hagiike; Hisashi Usuki; Yuka Yamamoto; Yoshihiro Nishiyama; Yasuyuki Suzuki
Journal:  World J Gastroenterol       Date:  2011-01-14       Impact factor: 5.742

5.  Association between the peroxisome proliferator-activated receptor gamma Pro12Ala variant and haplotype and pancreatic cancer in a high-risk cohort of smokers: a pilot study.

Authors:  Megan Dann Fesinmeyer; Janet L Stanford; Teresa A Brentnall; Margaret T Mandelson; Federico M Farin; Sengkeo Srinouanprachanh; Zahra Afsharinejad; Gary E Goodman; Matt J Barnett; Melissa A Austin
Journal:  Pancreas       Date:  2009-08       Impact factor: 3.327

Review 6.  Molecular epidemiology of pancreatic cancer.

Authors:  Donghui Li; Li Jiao
Journal:  Int J Gastrointest Cancer       Date:  2003

7.  Detection of Ki-ras mutations in tissue and plasma samples of patients with pancreatic cancer using PNA-mediated PCR clamping and hybridisation probes.

Authors:  J Däbritz; J Hänfler; R Preston; J Stieler; H Oettle
Journal:  Br J Cancer       Date:  2005-01-31       Impact factor: 7.640

8.  bcl-2-specific siRNAs restore gemcitabine sensitivity in human pancreatic cancer cells.

Authors:  Kinya Okamoto; Matthias Ocker; Daniel Neureiter; Otto Dietze; Steffen Zopf; Eckhart G Hahn; Christoph Herold
Journal:  J Cell Mol Med       Date:  2007-03-22       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.